• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

1350622-33-1 (kb-NB77-78)

1

Identification

kb-NB77-78 kb-NB77-78
Name kb-NB77-78
Formula C18H25NO3Si
MW 331.48
CAS No. 1350622-33-1
EINECS
Smiles O=C1OC2=CC=C(O[Si](C)(C(C)(C)C)C)C=C2C3=C1NCCC3
Synonyms 9-((tert-butyldimethylsilyl)oxy)-3,4-dihydro-1H-chromeno[3,4-b]pyridin-5(2H)-one
InChI InChI=1S/C18H25NO3Si/c1-18(2,3)23(4,5)22-12-8-9-15-14(11-12)13-7-6-10-19-16(13)17(20)21-15/h8-9,11,19H,6-7,10H2,1-5H3
2

Introduction

kb-NB77-78 is an analog of CID797718, which is a by-product of the synthesis of the parental compound, CID755673(PKD1 inhibitor).

Background Information

kb-NB77-78 is an analog of CID797718, which is a by-product of the synthesis of the parental compound, CID755673(PKD1 inhibitor). ......by BOC Sciences
kb-NB77-78 is an analogue of CID797718, but shows no PKD inhibitory activity[1]. ......by MedChemexpress Co., Ltd.
Kb-NB77-78 is a CID-797718 analog that may bind PKD1 ......by MedKoo Biosciences, Inc.
KB-NB77-78 is an analog of CID797718, which is a by-product of the synthesis of the parental compound, CID755673 (PKD1 inhibitor). ......by MedKoo Biosciences, Inc.
kb-NB77-78 is an analog of CID797718, which is a by-product of the synthesis of the parental compound, CID755673(PKD1 inhibitor). ......by Target Molecule Corp.
3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance:Light yellow to yellow Solid EBNumber:EB000010015

Storage condition

Solubility

DMSO by MedChemexpress Co., Ltd.
5

Mechanism and Indication

Signaling Pathways Apoptosis
Target PKD
Research Area Cancer
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
kb-NB77-78 - Not Found
kb-NB77-78 - No Development Reported
7

Safety Data of kb-NB77-78

8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
Apexbio Technology LLC 5mg/USD350(Ship Within 10-14 Days) USA
Ark Pharm, Inc. USA
BOC Sciences
Biochempartner Co., Ltd China
CHEMSCENE, LLC 5mg/USD420();10mg/USD600() USA
Cayman Chemical Company USA
DC Chemicals China
Lancrix Chemicals. 10mg/USD427() China
MedChemexpress Co., Ltd. 5mg/USD420();10mg/USD600() USA
MedKoo Biosciences, Inc. USA
MedKoo Biosciences, Inc. USA
Shanghai Haoyuan Chemexpress Co., Ltd. 5mg/USD420();10mg/USD600() China
Target Molecule Corp. 2mg/USD177();10mg/USD286();25mg/USD499();50mg/USD668();100mg/USD998() USA
10

Related Products

Other Forms of 1350622-33-1

Name CAS No Formula MW

Recommended Compounds in PKD

Name CAS No Formula MW
CID755673 521937-07-5 C12H11NO3 217.22
CID 2011756 638156-11-3 C22H21ClN2O3 396.87
kb NB 142-70 1233533-04-4 C11H9NO2S2 251.32
CRT0066101 dihydrochloride 1883545-60-5 C18H23ClN6O 374.8678

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

13

More Information

kb-NB77-78

Tags: buy 1350622-33-1 IC50 | 1350622-33-1 price | 1350622-33-1 cost | 1350622-33-1 solubility | 1350622-33-1 purchase | 1350622-33-1 manufacturer | 1350622-33-1 research buy | 1350622-33-1 order | 1350622-33-1 MSDS | 1350622-33-1 chemical structure | 1350622-33-1 Storage condition | 1350622-33-1 molecular weight | 1350622-33-1 mw | 1350622-33-1 datasheet | 1350622-33-1 supplier | 1350622-33-1 cell line | 1350622-33-1 NMR | 1350622-33-1 MS | 1350622-33-1 IR | 1350622-33-1 solubility | 1350622-33-1 Safe information | 1350622-33-1 Qc and Spectral Information | 1350622-33-1 Clinical Information | 1350622-33-1 Clinical Trial | 1350622-33-1 Route of Synthesis | 1350622-33-1 storage condition | 1350622-33-1 diseases and conditions | 1350622-33-1 flash point | 1350622-33-1 boiling point | 1350622-33-1 melting point | 1350622-33-1 storage condition | 1350622-33-1 brand